Not provided
Not provided
Not provided
Not provided
Low enrollment, lack of clinical staff support
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to examine the effectiveness of peppermint oil to promote voiding and reduce urinary catheterization among postpartum women.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Peppermint Oil Vapor | Active Comparator | Exposure of the perineum to the vapor of the active comparator, 2 ml peppermint oil. The perineum will NOT come into contact with the oil directly. |
|
| Mineral Oil Vapor | Placebo Comparator | Exposure of the perineum to the vapor of the placebo comparator, 2 ml mineral oil. The perineum will NOT come into contact with the oil directly. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Peppermint Oil Vapor | Other | 2ml of the oil will be placed in the urine collection "hat" that fits into the bowl of the toilet. Participants will then sit on the toilet in normal fashion, exposing their perineum to the vapor of the oil. The perineum will NOT come into contact with the oil directly - only the vapor from the oil will contact the perineum. |
| Measure | Description | Time Frame |
|---|---|---|
| Resolution of Postpartum Urinary Retention | Spontaneous bladder voiding of at least 150 milliliters | within 10 minutes after administering study intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Time to resolution of urinary retention | Time to resolution of postpartum urinary retention, defined as time from either 6 hours after vaginal delivery or within 6 hours after straight catheter in recovery or 6 hours after catheter removal for cesarean delivery to resolution of postpartum urinary retention. | Within 6 hours of postpartum urinary retention |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Study participants are postpartum women with urinary retention.
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Robin L Driver, BS | Mount Carmel Health System | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mount Carmel Health System | Columbus | Ohio | 43232 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016055 | Urinary Retention |
| ID | Term |
|---|---|
| D014555 | Urination Disorders |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
Not provided
Not provided
Randomized Controlled Trial
Not provided
Not provided
Not provided
|
| Mineral Oil Vapor | Other | 2ml of the mineral oil will be placed in the urine collection "hat" that fits into the bowl of the toilet. Participants will then sit on the toilet in normal fashion, exposing their perineum to the vapor of the oil. The perineum will NOT come into contact with the oil directly - only the vapor from the oil will contact the perineum. |
|
| Volume of urine voided | Volume of urine voided within 10 minutes after study intervention administration, expressed in milliliters | Within 6 hours of postpartum urinary retention |
| Patient Satisfaction Level | defined as patient rating of "agree" or "disagree" or "don't know" to the question, "I would recommend this treatment to other patients who cannot empty their bladder after delivering a baby." | Within one hour of study intervention administration |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |